Achmad T H, Rao G S
Institute of Clinical Biochemistry, University of Bonn, Germany.
Biochem Biophys Res Commun. 1992 Dec 15;189(2):994-1000. doi: 10.1016/0006-291x(92)92302-e.
The adherence of monocytes to the arterial endothelium followed by its migration into the arterial intima is the earliest event in atherogenesis. The vasoconstrictive peptide, Endothelin-1 (ET-1), is elevated in patients with atherosclerosis. We were interested to know whether ET-1 was a chemoattractant for blood monocytes. Using the modified membrane filter technique for chemotaxsis assessment, ET-1 increased monocyte chemotaxis in a dose-dependent manner. Ca2+ channel blockers, Nifedipine, Diltiazem and Verapamil (5 microM), reduced ET-1 chemotaxsis more than 60% (P < 0.001). Aspirin and Indomethacin (1 mM and 100 microM, respectively) reduced migration by 23% (P < 0.05). Alpha-Lipoic acid, Probucol and Neomycin (100 microM) were also migration inhibitory (37%, P < 0.01). These results suggest that ET-1 is a strong chemoattractant for blood monocytes; Ca2+ influx is probably the major stimulus for the accelerated migration induced by ET-1.
单核细胞黏附于动脉内皮,随后迁移至动脉内膜,这是动脉粥样硬化发生过程中最早出现的事件。血管收缩肽内皮素-1(ET-1)在动脉粥样硬化患者中水平升高。我们想了解ET-1是否是血液单核细胞的趋化因子。使用改良的膜滤技术评估趋化作用,ET-1以剂量依赖的方式增加单核细胞趋化性。钙通道阻滞剂硝苯地平、地尔硫䓬和维拉帕米(5微摩尔)使ET-1趋化作用降低超过60%(P<0.001)。阿司匹林和吲哚美辛(分别为1毫摩尔和100微摩尔)使迁移减少23%(P<0.05)。α-硫辛酸、普罗布考和新霉素(100微摩尔)也具有迁移抑制作用(37%,P<0.01)。这些结果表明,ET-1是血液单核细胞的强效趋化因子;钙内流可能是ET-1诱导加速迁移的主要刺激因素。